Overall Rating


(3.2/5) Neutral

Sanofi-Aventis (SNY)

Price*: $27.35 | Dividend: $0.99 | Dividend Yield: 3.62%

Recommendation Info
This stock has never had a high enough Dividend.com Rating to qualify for our Best Dividend Stocks list.
Dividend Stock Ratings Breakdown Dividend Stock Ratings Breakdown
1. Relative Strength   What's This?

Stock is in a solid downturn.
2. Overall Yield Attractiveness   What's This?

Stock's dividend yield is above average.
3. Dividend Reliability   What's This?

This rating is directly related to the length and consistency of a company's dividend payouts.
4. Dividend Uptrend   What's This?

Dividend payouts are consistent, but increases small.
5. Earnings Growth   What's This?

Earnings estimates have been raised slightly.
Price and Dividend Info Price and Dividend Info
Sanofi-Aventis (SNY)
Previous Day's Closing Price*
$27.35
Annual Stock Dividend
$0.99
Current Dividend Yield
3.62%

Recent Headlines Recent Headlines

Dividend Stock Profile & Recommendation Profile & Recommendation

Company Profile Company Profile

Sanofi-Aventis- (SNY)-engages in the research, development, manufacture, and marketing of healthcare products worldwide. It offers products in various therapeutic fields, including cardiovascular, thrombosis, oncology, metabolic disorders, central nervous system, and internal medicine and vaccines. The company was founded in 1970 and is headquartered in Paris, France.

Dividend Stock Recommendation - Neutral Recommendation

Based on our rating criteria, this stock has achieved a "Neutral" rating. Stocks with a neutral rating are considered mediocre investments in terms of expected price growth and dividend payments.

Stock Notes Stock Notes

This large cap stock does not make an attractive dividend stock investment at this time.

* Stock price reflects previous day's closing price. All stock quotes on this website should be considered as having a 24-hour delay.

** Under no circumstances does the information in this column represent a recommendation to buy or sell stocks. The author is not registered as an investment adviser. The author may or may not hold positions in the securities mentioned in this article or video. The author relies upon the "publisher's exclusion" from the definition of "investment adviser" as provided under Section 202(a)(11) of the Investment Advisers Act of 1940 and corresponding state securities laws.